portrait

Ena Slavkovic

Yugoslavia

Translate From: English (EN)

Translate To: Serbian (SR)

1,230

Words Translated

0

Terms Translated

Ena’s Selected Translation Work

Terms and text shown below represent Ena’s contributions to TermWiki.com, a free terminology website and knowledge resource for the translation community.

(object) array( 'id' => '1461311', 'url' => 'SR/Family_and_Medical_Leave_Act', 'image' => '', 'title' => 'Zakon o porodičnom i zdravstvenom odsustvu', 'tags' => array ( 0 => 'Zakon o porodičnom i zdravstvenom odsustvu', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'Zakon o porodičnom i zdravstvenom odsustvu', 'source_id' => 40085, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705223510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Ovaj zakon nalaže da poslodavci moraju omogućiti najviše 12 nedelja neplaćenog odsustva kvalifikovanim zaposlenima.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813700, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Family and Medical Leave Act', 'Definition' => 'This act stipulates that employers must provide up to 12 weeks of unpaid leave to eligible employees.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Family_and_Medical_Leave_Act', )

English (EN)Family and Medical Leave Act

This act stipulates that employers must provide up to 12 weeks of unpaid leave to eligible employees.

Serbian (SR)Zakon o porodičnom i zdravstvenom odsustvu

Ovaj zakon nalaže da poslodavci moraju omogućiti najviše 12 nedelja neplaćenog odsustva kvalifikovanim zaposlenima.

Business services; Human resources
(object) array( 'id' => '1461300', 'url' => 'SR/business_casual', 'image' => '', 'title' => 'poslovno ležerni (stil)', 'tags' => array ( 0 => 'poslovno ležerni (stil)', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'poslovno ležerni (stil)', 'source_id' => 40066, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Standardni stil oblačenja (dress code) u većini firmi, kojim se zadržava profesionalna atmosfera a uz to i zaposleni se osećaju udobno.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967779667968, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'business casual', 'Definition' => 'The standard dress code in most offices, which preserves a professional atmosphere while ensuring that employees are comfortable.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'business_casual', )

English (EN)business casual

The standard dress code in most offices, which preserves a professional atmosphere while ensuring that employees are comfortable.

Serbian (SR)poslovno ležerni (stil)

Standardni stil oblačenja (dress code) u većini firmi, kojim se zadržava profesionalna atmosfera a uz to i zaposleni se osećaju udobno.

Business services; Human resources
(object) array( 'id' => '1461317', 'url' => 'SR/market_entry', 'image' => '', 'title' => 'ulazak na tržište', 'tags' => array ( 0 => 'ulazak na tržište', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'ulazak na tržište', 'source_id' => 54584, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pokušaj kompanije da uđe na tržište preko inovacija, javne nabavke ili ekspanzijeć', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862276, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'market entry', 'Definition' => 'An attempt by a company to enter a market through innovation, acquisition or expansion.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'market_entry', )

English (EN)market entry

An attempt by a company to enter a market through innovation, acquisition or expansion.

Serbian (SR)ulazak na tržište

Pokušaj kompanije da uđe na tržište preko inovacija, javne nabavke ili ekspanzijeć

Business services; Marketing
(object) array( 'id' => '1467647', 'url' => 'SR/study_type', 'image' => '', 'title' => 'tip studje', 'tags' => array ( 0 => 'tip studje', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'tip studje', 'source_id' => 30943, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709204525', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Primarne tehnike ispitivanja korišćene u protokolu observacije; tipovi su Svrha, Trajanje, Selekcija i Tajming', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999174033410, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'study type', 'Definition' => 'The primary investigative techniques used in an observational protocol; types are Purpose, Duration, Selection, and Timing.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'study_type', )

English (EN)study type

The primary investigative techniques used in an observational protocol; types are Purpose, Duration, Selection, and Timing.

Serbian (SR)tip studje

Primarne tehnike ispitivanja korišćene u protokolu observacije; tipovi su Svrha, Trajanje, Selekcija i Tajming

Pharmaceutical; Clinical trials
(object) array( 'id' => '1461048', 'url' => 'SR/phase_ii_trials', 'image' => '', 'title' => 'Druga faza ispitivanja', 'tags' => array ( 0 => 'Druga faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Druga faza ispitivanja', 'source_id' => 30917, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kontrolisane kliničke studije koje se sprovode sa ciljem procene efikasnosti leka za određenu indikaciju ili indikacije kod pacijenta sa oboljenjem ili stanjem koje se ispituje kao i determinacije uobičajenih kratkotrajnih neželjenih dejstava i rizka.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247811, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase ii trials', 'Definition' => 'Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_ii_trials', )

English (EN)phase ii trials

Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.

Serbian (SR)Druga faza ispitivanja

Kontrolisane kliničke studije koje se sprovode sa ciljem procene efikasnosti leka za određenu indikaciju ili indikacije kod pacijenta sa oboljenjem ili stanjem koje se ispituje kao i determinacije uobičajenih kratkotrajnih neželjenih dejstava i rizka.

Pharmaceutical; Clinical trials
(object) array( 'id' => '1460603', 'url' => 'SR/meta-analysis_₁', 'image' => '', 'title' => 'meta-analiza', 'tags' => array ( 0 => 'meta-analiza', 1 => 'Education', 2 => 'Teaching', 3 => 'Teachnology', 4 => '', ), 'term' => 'meta-analiza', 'source_id' => 712334, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Education', ), 'category' => array ( 0 => 'Teaching', ), 'company' => array ( 0 => 'Teachnology', ), 'lastedit' => '20110705082507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Statistička procedura za inegraciju rezultata različitih studija.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964694757377, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'meta-analysis', 'Company' => 'Teachnology', 'Definition' => 'Statistical procedure for integrating the results of different studies.', 'Domain' => 'Documentation', 'Industry' => 'Education', 'Part of Speech' => 'noun', 'Product Category' => 'Teaching', 'Usage Status' => 'New', 'Creation User' => 'katesd', 'Creation Date' => '2011/2/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'meta-analysis_₁', )

English (EN)meta-analysis

Statistical procedure for integrating the results of different studies.

Serbian (SR)meta-analiza

Statistička procedura za inegraciju rezultata različitih studija.

Education; Teaching
(object) array( 'id' => '1461049', 'url' => 'SR/phase_iii_trials', 'image' => '', 'title' => 'Treća faza ispitivanja', 'tags' => array ( 0 => 'Treća faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Treća faza ispitivanja', 'source_id' => 30918, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155511', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Proširena kontrolisana i nekontrolisana ispitivanja posle preliminarne evidencije kojom je postignuta efikasnost leka i kojom se namerava prikupljanje dodatnih informacija za procenu sveukupnog odnosa korist-rizik leka i omogući adekvatna osnova za lekara opšte prakse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247812, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iii trials', 'Definition' => 'Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iii_trials', )

English (EN)phase iii trials

Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and ...

Serbian (SR)Treća faza ispitivanja

Proširena kontrolisana i nekontrolisana ispitivanja posle preliminarne evidencije kojom je postignuta efikasnost leka i kojom se namerava prikupljanje dodatnih informacija za procenu sveukupnog odnosa korist-rizik leka i omogući adekvatna osnova za lekara ...

Pharmaceutical; Clinical trials
(object) array( 'id' => '1461318', 'url' => 'SR/price_ceiling', 'image' => '', 'title' => 'maksimalna cena', 'tags' => array ( 0 => 'maksimalna cena', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'maksimalna cena', 'source_id' => 54604, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Maksimalna cena može biti određena bilo zakonskim ili tržišnim uslovima.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862277, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'price ceiling', 'Definition' => 'The maximum the price can be set, whether by law or market conditions.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'price_ceiling', )

English (EN)price ceiling

The maximum the price can be set, whether by law or market conditions.

Serbian (SR)maksimalna cena

Maksimalna cena može biti određena bilo zakonskim ili tržišnim uslovima.

Business services; Marketing
(object) array( 'id' => '1460561', 'url' => 'SR/thrombolytic_therapy', 'image' => '', 'title' => 'trombolitička terapija', 'tags' => array ( 0 => 'trombolitička terapija', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'trombolitička terapija', 'source_id' => 1047729, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074502', 'part_of_speech' => 'other', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Upotreba lekova u cilju razbijanja ili rastvaranja krvnih ugrušaka, koji su glavni uzrok i srčanog i moždanog udara.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964533276677, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'thrombolytic therapy', 'Definition' => 'Use of drugs to break up or dissolve blood clots, which are the main cause of both heart attacks and stroke.', 'Part of Speech' => 'other', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Creation User' => 'CCTRADUCTION', 'Creation Date' => '2011/4/13', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'thrombolytic_therapy', )

English (EN)thrombolytic therapy

Use of drugs to break up or dissolve blood clots, which are the main cause of both heart attacks and stroke.

Serbian (SR)trombolitička terapija

Upotreba lekova u cilju razbijanja ili rastvaranja krvnih ugrušaka, koji su glavni uzrok i srčanog i moždanog udara.

Pharmaceutical; Drugs
(object) array( 'id' => '1461314', 'url' => 'SR/balance_of_payments', 'image' => '', 'title' => 'platni bilansi', 'tags' => array ( 0 => 'platni bilansi', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'platni bilansi', 'source_id' => 54534, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705224502', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Evidencija svih monetarnih transakcija između jedne države i svih drugih država zajedno.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862273, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'balance of payments', 'Definition' => 'A record of all monetary transactions between one country and all other country combined.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'balance_of_payments', )

English (EN)balance of payments

A record of all monetary transactions between one country and all other country combined.

Serbian (SR)platni bilansi

Evidencija svih monetarnih transakcija između jedne države i svih drugih država zajedno.

Business services; Marketing